BSE Live
Sep 25, 16:01Prev. Close
447.30
Open Price
451.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 25, 15:59Prev. Close
449.85
Open Price
458.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
446.25 (29)
Balance Sheet of Venus Remedies (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 11.44 | 11.44 | 10.54 | 9.74 | 9.13 | |
Total Share Capital | 11.44 | 11.44 | 10.54 | 9.74 | 9.13 | |
Reserves and Surplus | 454.79 | 455.97 | 376.92 | 300.35 | 233.27 | |
Total Reserves and Surplus | 454.79 | 455.97 | 376.92 | 300.35 | 233.27 | |
Total Shareholders Funds | 466.24 | 467.42 | 387.46 | 319.11 | 246.59 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 168.56 | 139.51 | 129.12 | 99.13 | 87.98 | |
Deferred Tax Liabilities [Net] | 14.78 | 17.79 | 14.68 | 11.64 | 9.24 | |
Other Long Term Liabilities | 0.69 | 0.67 | 0.47 | 0.23 | 0.24 | |
Long Term Provisions | 3.78 | 3.31 | 2.91 | 2.50 | 1.94 | |
Total Non-Current Liabilities | 187.81 | 161.27 | 147.18 | 113.50 | 99.41 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 115.40 | 110.08 | 95.68 | 83.24 | 63.17 | |
Trade Payables | 25.76 | 28.14 | 17.87 | 12.33 | 6.11 | |
Other Current Liabilities | 47.68 | 54.60 | 57.88 | 43.22 | 40.27 | |
Short Term Provisions | 1.91 | 14.51 | 18.63 | 15.33 | 15.14 | |
Total Current Liabilities | 190.75 | 207.33 | 190.06 | 154.13 | 124.69 | |
Total Capital And Liabilities | 844.80 | 836.02 | 729.48 | 586.74 | 470.69 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 196.00 | 198.16 | 183.29 | 164.36 | 152.17 | |
Intangible Assets | 229.77 | 217.93 | 197.63 | 171.50 | 121.87 | |
Capital Work-In-Progress | 70.29 | 61.56 | 43.67 | 17.78 | 10.42 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 504.07 | 483.89 | 428.73 | 358.86 | 289.35 | |
Non-Current Investments | 28.74 | 28.74 | 28.74 | 28.74 | 28.37 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 51.65 | 54.98 | 42.74 | 26.01 | 13.91 | |
Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Assets | 584.46 | 567.61 | 500.20 | 413.61 | 331.63 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 140.44 | 141.46 | 126.40 | 96.19 | 75.43 | |
Trade Receivables | 59.37 | 62.80 | 53.11 | 44.33 | 36.41 | |
Cash And Cash Equivalents | 3.52 | 4.38 | 6.26 | 2.91 | 2.91 | |
Short Term Loans And Advances | 57.01 | 59.77 | 43.51 | 29.70 | 24.11 | |
OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.20 | |
Total Current Assets | 260.34 | 268.41 | 229.28 | 173.13 | 139.07 | |
Total Assets | 844.80 | 836.02 | 729.48 | 586.74 | 470.69 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 5.58 | 7.10 | 18.80 | 4.11 | 4.48 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 82.15 | 92.05 | 69.48 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.37 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | 0.01 | 0.01 | 0.01 | 0.01 | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 28.74 | 28.74 | 28.74 | 28.74 | 28.37 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y